2016 Antibody Biology and Engineering Gordon Research Conference & Gordon Research Seminar

2016年抗体生物学与工程戈登研究会议

• 批准号: 9051582
• 负责人: Richard S Blumberg
• 金额: $ 0.4万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-02-15 至 2016-04-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9051582
• 关键词: Academia; Address; Antibodies; Antibody Diversity; Area; Autoimmune Diseases; Autoimmunity; Basic Science; Biological Products; Biology; Bispecific Antibodies; Clinic; Clinical Treatment; Clinical Trials; Collaborations; Communities; Data; Development; Discipline; Disease; Elements; Engineering; Ensure; Fc Receptor; Future; Future Generations; Generations; Immune; Immunoglobulins; Industry; Infection; Inflammation; Inflammatory; Influentials; International; Investigation; Malignant Neoplasms; Mediating; Mentors; Mentorship; Monoclonal Antibodies; Participant; Pharmacologic Substance; Postdoctoral Fellow; Reagent; Recording of previous events; Reporting; Research; Research Activity; Research Personnel; Role; Running; Scientist; Series; Structure; System; Texas; Therapeutic; Therapeutic Intervention; Time; Visit; Work; abstracting; antibody engineering; base; career; clinical application; collaborative environment; design; forging; graduate student; immunoglobulin structure; insight; meetings; novel therapeutics; oncology; peer; posters; programs; protective effect; public health relevance; symposium

 DESCRIPTION (provided by the applicant): This application seeks partial support for the 2016 Gordon Research Conference (GRC) on Antibody Biology and Engineering, together with an accompanying Gordon Research Seminar (GRS) to be held on March 20 -28, 2016 at the Hotel Galvez in Galveston, Texas. This is the fourth GRC and the second GRS on this topic which is representative of a highly exciting and influential meeting in the community. The aim of this meeting is to provide in-depth coverage of important recent developments in the rapidly evolving field of antibody biology and engineering in an informal setting designed for maximal discussion and interaction. This field has broad implications for a wide variety of biologically an clinically important topics. The GRS will run immediately prior to the GRC and will provide seminar and poster sessions specifically for graduate students and post-doctoral scientists to allow them to present and discuss their research. A GRS keynote speaker, together with the GRC chairs, will offer support and advice through a mentorship session and continuous interactions with the trainees during the course of the GRS meeting. Spanning topics from basic research through to clinical applications and having a very dynamic mix of scientists from academia and industry, the GRC will host approximately 26-30 talks from invited speakers. A further 10-14 shorter talks that are primarily from young scientists that will be selected from submitted abstracts is also envisioned. The GRC will also incorporate 4 poster sessions. The GRC plans on two keynote speakers, 1 from academia and 1 from industry, both of whom are internationally recognized experts in their respective areas. The topics that are planned for the GRC include: A. Antibody structure and dynamics in relations to function; B. Modifying antibody diversity - it's generation and uses; C. The functionality of antibodies and the receptors through which they operate; D. Development and mechanisms of pathogenic or protective antibodies; E. Unique therapeutic vistas in antibody biology engineering and specifically the role of bispecific antibodies; F. Co-opting antibodies as a delivery vehicle, and; G. Therapeutic challenges and opportunities in the application of antibodies to modify disease. The conference will report the most recent unpublished advances in research activity at the leading edge of international efforts in a field that has particular relevance to clinical treatment in that many new drugs reaching the clinic or in development are based on immunoglobulins or their derivatives. Building on the long history of creative academia-industry interactions which have characterized the three previous meetings in this series, this GRC and GRS will provide an ideal opportunity for academic and bio-pharma researchers from around the world to network and forge new collaborations. We envision that novel therapeutic applications are likely to ensue from this cross pollination of ideas. Furthermore, by providing opportunities for younger researchers to present their studies and discuss their work with more established scientists in both academia and industry, this meeting will act as an important spring board for the development of future scientific leaders in this rapidly emerging field.

 描述（由申请人提供）：本申请寻求对 2016 年戈登抗体生物学和工程研究会议 (GRC) 以及将于 2016 年 3 月 20 日至 28 日在德克萨斯州加尔维斯敦酒店这是关于该主题的第四次 GRC 和第二次 GRS，这是社区中非常激动人心且具有影响力的会议的代表。 GRS 将在非正式的环境中深入报道快速发展的抗体生物学和工程领域的重要最新进展，该领域对各种生物学和临床重要主题具有广泛的影响。在 GRC 之前，将专门为研究生和博士后科学家提供研讨会和海报会议，以便他们展示和讨论他们的研究。GRS 主讲人将与 GRC 主席一起，通过指导提供支持和建议。课程以及与学员的持续互动在 GRS 会议期间，GRC 将举办约 26-30 场受邀演讲嘉宾的演讲，主题涵盖从基础研究到临床应用的各个领域，汇聚了来自学术界和工业界的科学家。预计 GRC 还将举办 4 场墙报会议，由两位主题演讲嘉宾组成，其中 1 名来自学术界，1 名来自工业界。 GRC 计划的主题包括： A. 抗体。 与功能相关的结构和动态；B. 改变抗体多样性 - 其产生和使用；C. 抗体及其发挥作用的受体的功能；D. 致病性或保护性抗体的发展和机制；抗体生物工程，特别是双特异性抗体的作用；F. 选择抗体作为递送载体；G. 应用抗体改变疾病的治疗挑战和机遇。活动于在与临床治疗特别相关的领域中，国际努力处于领先地位，因为许多到达临床或正在开发的新药都是基于免疫球蛋白或其衍生物，这是建立在学术界与工业界创造性互动的悠久历史之上的，这也是这三种药物的特点。与本系列之前的会议一样，此次 GRC 和 GRS 将为来自世界各地的学术和生物制药研究人员提供一个建立网络和建立新合作的理想机会，我们预计这种思想的交叉传播可能会产生新的治疗应用。此外，通过此次会议为年轻研究人员提供了展示研究成果并与学术界和工业界更知名的科学家讨论其工作的机会，将成为这一快速新兴领域未来科学领袖发展的重要跳板。